| 000 | 01052 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517150410.0 | ||
| 264 | 0 | _c20181031 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1097-4598 | ||
| 024 | 7 |
_a10.1002/mus.25663 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYost, Micah D | |
| 245 | 0 | 0 |
_aFacial diplegia after pembrolizumab treatment. _h[electronic resource] |
| 260 |
_bMuscle & nerve _c09 2017 |
||
| 300 |
_aE20-E21 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xadverse effects |
| 650 | 0 | 4 |
_aFacial Paralysis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aChou, Claudia Z | |
| 700 | 1 | _aBotha, Hugo | |
| 700 | 1 | _aBlock, Matthew S | |
| 700 | 1 | _aLiewluck, Teerin | |
| 773 | 0 |
_tMuscle & nerve _gvol. 56 _gno. 3 _gp. E20-E21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/mus.25663 _zAvailable from publisher's website |
| 999 |
_c27070490 _d27070490 |
||